Jentashapir Journal of Health Research

Published by: Kowsar

Biotinidase, as a Convenient Diagnostic and Prognostic Marker for Breast Cancer

Nader Saki 1 , Soheila Nikakhlagh 1 and Gholamabbas Dinarvand 1 , *
Authors Information
1 Cancer Research Center, Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jentashapir Journal of Health Research: February 01, 2015, 6 (1); e27207
  • Published Online: February 21, 2015
  • Article Type: Discussion
  • Received: January 21, 2015
  • Accepted: February 2, 2015
  • DOI: 10.5812/jjhr.27207

To Cite: Saki N, Nikakhlagh S, Dinarvand G. Biotinidase, as a Convenient Diagnostic and Prognostic Marker for Breast Cancer, Jentashapir J Health Res. 2015 ; 6(1):e27207. doi: 10.5812/jjhr.27207.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Hypothesis
3. Consequences of the Hypothesis and Conclusion
  • 1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4): 225-49[DOI][PubMed]
  • 2. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, et al. The case for early detection. Nat Rev Cancer. 2003; 3(4): 243-52[DOI][PubMed]
  • 3. Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006; 24(31): 5091-7[DOI][PubMed]
  • 4. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002; 1(11): 845-67[PubMed]
  • 5. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics. 2005; 5(13): 3226-45[DOI][PubMed]
  • 6. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Breast cancer. Lancet. 2005; 365(9472): 1727-41[DOI][PubMed]
  • 7. Tuli R, Flynn RA, Brill KL, Sabol JL, Usuki KY, Rosenberg AL. Diagnosis, treatment, and management of breast cancer in previously augmented women. Breast J. 2006; 12(4): 343-8[DOI][PubMed]
  • 8. Aebersold R, Anderson L, Caprioli R, Druker B, Hartwell L, Smith R. Perspective: a program to improve protein biomarker discovery for cancer. J Proteome Res. 2005; 4(4): 1104-9[DOI][PubMed]
  • 9. Hartwell L, Mankoff D, Paulovich A, Ramsey S, Swisher E. Cancer biomarkers: a systems approach. Nat Biotechnol. 2006; 24(8): 905-8[DOI][PubMed]
  • 10. Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, Yoshimura K, et al. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Sci. 2004; 95(12): 955-61[PubMed]
  • 11. Somiari RI, Somiari S, Russell S, Shriver CD. Proteomics of breast carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; 815(1-2): 215-25[DOI][PubMed]
  • 12. Lo WY, Tsai MH, Tsai Y, Hua CH, Tsai FJ, Huang SY, et al. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta. 2007; 376(1-2): 101-7[DOI][PubMed]
  • 13. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol. 2006; 24(8): 971-83[DOI][PubMed]
  • 14. Hu S, Loo JA, Wong DT. Human body fluid proteome analysis. Proteomics. 2006; 6(23): 6326-53[DOI][PubMed]
  • 15. Siriwardana G, Bradford A, Coy D, Zeitler P. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol Endocrinol. 2006; 20(9): 2010-9[DOI][PubMed]
  • 16. Kim DH, Bae J, Lee JW, Kim SY, Kim YH, Bae JY, et al. Proteomic analysis of breast cancer tissue reveals upregulation of actin-remodeling proteins and its relevance to cancer invasiveness. Proteomics Clin Appl. 2009; 3(1): 30-40[DOI][PubMed]
  • 17. Chang JW, Kang UB, Kim DH, Yi JK, Lee JW, Noh DY, et al. Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer. Proteomics Clin Appl. 2008; 2(1): 23-32[DOI][PubMed]
  • 18. Thoma RW, Peterson WH. The enzymatic degradation of soluble bound biotin. J Biol Chem. 1954; 210(2): 569-79[PubMed]
  • 19. Wright LD, Driscoll CA, Boger WP. Biocytinase, an enzyme concerned with hydrolytic cleavage of biocytin. Proc Soc Exp Biol Med. 1954; 86(2): 335-7[PubMed]
  • 20. Pispa J. Animal biotinidase. Ann Med Exp Biol Fenn. 1965; 43-39[PubMed]
  • 21. Stanley JS, Griffin JB, Zempleni J. Biotinylation of histones in human cells. Effects of cell proliferation. Eur J Biochem. 2001; 268(20): 5424-9[PubMed]
  • 22. Hymes J, Fleischhauer K, Wolf B. Biotinylation of histones by human serum biotinidase: assessment of biotinyl-transferase activity in sera from normal individuals and children with biotinidase deficiency. Biochem Mol Med. 1995; 56(1): 76-83[PubMed]
  • 23. Narang MA, Dumas R, Ayer LM, Gravel RA. Reduced histone biotinylation in multiple carboxylase deficiency patients: a nuclear role for holocarboxylase synthetase. Hum Mol Genet. 2004; 13(1): 15-23[DOI][PubMed]
  • 24. Sarath G, Kobza K, Rueckert B, Camporeale G, Zempleni J, Haas E. Biotinylation of human histone H3 and interactions with biotinidase. FASEB J. 2004; 18(4)
  • 25. Wolf B, Grier RE, Allen RJ, Goodman SI, Kien CL. Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. Clinica Chimica Acta. 1983; 131(3): 273-81[DOI]
  • 26. Peters DM, Griffin JB, Stanley JS, Beck MM, Zempleni J. Exposure to UV light causes increased biotinylation of histones in Jurkat cells. Am J Physiol Cell Physiol. 2002; 283(3)-84[DOI][PubMed]
  • 27. Kothapalli N, Zempleni J. Double strand breaks of DNA decrease biotinylation of lysine-12 in histone H4 in JAr cells. FASEB J. 2004; 18(4)-4
  • 28. Kang UB, Ahn Y, Lee JW, Kim YH, Kim J, Yu MH, et al. Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker. BMC Cancer. 2010; 10: 114[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments